TriMas (TRS) Q1 2026 Earnings Transcript

DATE

Thursday, April 30, 2026 at 10 a.m. ET

CALL PARTICIPANTS

• President & Chief Executive Officer — Thomas Snyder
• Chief Financial Officer — Paul Swart
• Vice President of Investor Relations & Communications — Sherry Lauderback

TAKEAWAYS

• Aerospace Divestiture Proceeds -- The completed divestiture of TriMas Aerospace on March 16 generated over $1.2 billion in net after-tax proceeds, enhancing financial flexibility.
• Share Repurchases -- Nearly 1.5 million shares were repurchased during the quarter, totaling approximately 4.5 million since the divestiture announcement, resulting in 36.3 million shares outstanding at quarter end.
• Net Sales -- Net sales rose more than 10% year over year to $168 million, primarily from 7.3% organic growth and a 4% currency benefit, partially offset by divestiture impact.
• Operating Margin -- Operating margin expanded by 120 basis points, driven by volume leverage and cost-saving initiatives.
• Income from Continuing Operations -- Income increased 51% to $9 million compared to $5.9 million in the prior year.
• Adjusted Diluted EPS -- Adjusted diluted earnings per share grew 60% to $0.24, up from $0.15 a year ago, supported by $0.04 of interest income from invested divestiture proceeds.
• Net Cash Balance -- The company ended the quarter with net cash of $913 million, earning about 3.5% interest in invested accounts.
• Debt Position -- $400 million of 4.25% senior notes due 2029 remains outstanding as stable, low-cost financing.
• Free Cash Flow -- Free cash flow was a use of $16 million, which management cited as typical given first quarter seasonality.
• Packaging Segment Sales -- Net sales increased 9.1% to $139.2 million, with demand strongest in beauty and personal care and life sciences, offset by softness in industrial closures.
• Packaging Segment Margin -- Sequential margin improvement was noted versus prior quarters, but year-over-year margins declined due to higher tooling sales in life sciences at low margin.
• Specialty Products Sales -- Net sales grew 17% to $29.1 million, with Norris Cylinder sales up 24% and offsetting a $1.4 million decline from the 2025 divestiture.
• Specialty Products Margin -- Operating profit rose to $2.9 million from $0.1 million, with margin expanding 940 basis points to 9.8% on improving demand and cost absorption.
• Cost-Out Initiatives -- Actions under way are expected to deliver $10 million of cost savings in 2026 and $15 million annually; further $0.5 million in 2026 and $1 million annualized from facility consolidation.
• Full-Year Sales Guidance -- 2026 full-year sales growth is expected in the 3%-6% range, based on a $645.7 million 2025 revenue base.
• Full-Year Operating Margin Guidance -- Management projects a more than 300 basis point increase from the 2025 operating margin of 5.3%.
• Adjusted EPS Guidance -- Full-year 2026 adjusted diluted earnings per share is guided at $1.50 to $1.70, a 191% increase at the midpoint from $0.55 in 2025.
• Interest Income Expectation -- Management anticipates $9 million of interest income across the remainder of 2026, barring significant changes in rates or redeployment.
• Tax Rate Guidance -- The 2026 effective tax rate is projected between 27% and 29%.
• Capital Allocation -- Strategy is to invest in organic growth, target acquisitions in packaging and life sciences, and return capital to shareholders.

Need a quote from a Motley Fool analyst? Email pr@fool.com

RISKS

• Thomas Snyder indicated possible "headwind in the quarter with some delay" in passing resin cost increases through contracts, suggesting "we may not get full recovery on some of it until the third quarter or later in the year," potentially impacting Packaging segment margins in Q2.
• First quarter free cash flow was a use of $16 million, which management stated is normal for the season, and they expect improved free cash flow generation as the year progresses.
• The outlook assumes no significant changes in interest rates or major redeployment of divestiture proceeds, which could adversely affect the projected $9 million interest income.

SUMMARY

The completion of the TriMas Aerospace divestiture provided over $1.2 billion in after-tax proceeds, resulting in substantial balance sheet transformation and net cash of $913 million. Management expects to accelerate growth and profitability in 2026, guided by 3%-6% sales growth, a more than 300 basis point operating margin increase, and adjusted diluted EPS of $1.50 to $1.70. Year-over-year gains were driven by major cost savings initiatives, higher volumes in core Packaging and Specialty Products, and rising interest income from invested proceeds.

• Paul Swart noted that "The majority of our cash balance is invested in interest-bearing accounts, currently earning about 3.5%," providing material income as management defers capital redeployment for strategic opportunities.
• Thomas Snyder described the $10 million cost-out target for 2026 and $15 million annually as "not aspirational targets—these actions have already been taken and are progressing as planned."
• Facility consolidation in Atkins, Arkansas, is expected to contribute approximately $0.5 million in 2026 cost savings and roughly $1 million annually after full implementation, with operational improvements cited as a key segment profitability driver.
• One-time life sciences tooling sales delivered a near-term revenue benefit but compressed margins; management said, "we do not expect that margin pressure to occur for the remainder of the year."
• Leadership views Packaging and life sciences as "attractive, growing, and resilient end markets," and cited an ongoing focus on targeted, high-quality acquisitions to expand these platforms.

INDUSTRY GLOSSARY

• Tooling Revenue: Proceeds from the sale of tools or equipment to a customer, typically at low margin, and often associated with upcoming product launches in manufacturing businesses.

Full Conference Call Transcript

Sherry Lauderback: Thank you, and welcome to TriMas Corporation's First Quarter 2026 Earnings Call. Joining me today are Thomas Snyder, President and CEO, and Paul Swart, our Chief Financial Officer. We will begin with prepared remarks discussing our first quarter results, followed by our outlook for 2026, after which we will open the call for your questions. To help you follow along with today's discussion, both the press release and our presentation are available on our website at trimas.com under the Investors section. A replay of this call will also be available later today by dialing (877) 660-6853 and using meeting ID 13759871.

Before we begin, I would like to remind everyone that today's comments may include forward-looking statements, which are inherently subject to various risks and uncertainties. Please refer to our most recent Forms 10-K and 10-Q for a discussion of the factors that could cause our results to differ from those anticipated in any forward-looking statements. We undertake no obligation to publicly update or revise such statements except as required by law. We also encourage you to visit our website for more information. In addition, please refer to the appendix of our press release or presentation for reconciliations of GAAP to non-GAAP financial measures.

Throughout today's call, our discussion of financial results will be on an adjusted basis, excluding the impact of special items, and unless otherwise noted, the financial results discussed will reflect continuing operations. At this point, I will turn the call over to Thomas Snyder. Thomas?

Thomas Snyder: Thank you, Sherry. Good morning, everyone, and thank you for joining us today. Before diving into the results, I want to briefly provide some perspective on the quarter. The first quarter of 2026 reflected steady execution and progress as we advanced several important priorities for the company. During the quarter, our team delivered on several key commitments, most notably the successful divestiture of TriMas Aerospace, which closed on March 16. The transaction was completed on schedule, generated more than $1.2 billion of net after-tax proceeds, and meaningfully strengthened our balance sheet. We are pleased with the execution and the increased flexibility this provides as we move forward.

We acted promptly and deliberately with the proceeds, repaying borrowings associated with fourth quarter share repurchase activity, completing additional share repurchases, and investing the remaining balance in interest-bearing accounts as we assess the best long-term use of that capital. During the first quarter, we repurchased nearly 1.5 million shares, bringing total repurchases since announcing the aerospace divestiture to approximately 4.5 million shares. As of quarter end, we had approximately 36.3 million shares outstanding. These actions reflect our disciplined approach to capital allocation, including returning capital to shareholders while maintaining the flexibility to invest for long-term value creation.

Our priorities remain unchanged: investing in organic growth, strengthening our core capabilities, and pursuing targeted, high-quality acquisitions that enhance, elevate, or expand our platforms within packaging and life sciences. We believe these are attractive, growing, and resilient end markets where we see compelling long-term opportunities and where our capabilities position us well to compete and win. While much of the focus this year has been on the aerospace divestiture and our longer-term strategic positioning, we also continued to make meaningful progress on operational improvements across the business.

We intensified our focus on standardization, operational excellence, and continuous improvement, and as discussed on our February call, we took actions that position us to deliver approximately $10 million of cost savings in 2026 and $15 million annually. Based on that momentum, in March, we announced plans to consolidate our Atkins, Arkansas packaging facility into other locations by midyear 2026. This was a difficult but necessary decision that aligns with our long-term strategy to optimize our manufacturing footprint, improve efficiency, and remain competitive. We expect this action to generate approximately $0.5 million of additional savings in 2026 and roughly $1 million on an annualized basis. Alongside this progress on execution and strategy, we are operating in a dynamic external environment.

Our teams are closely monitoring geopolitical developments, including conditions in the Middle East, and proactively managing potential impacts across our operations and supply chains. While we have not experienced any significant direct impacts to date, we are working collaboratively with our vendors and customers to manage cost pressures and ensure continuity of supply. Despite these external considerations, our focus remains firmly on what we can control. As we move through the remainder of 2026, we believe we are well positioned to accelerate performance, invest in organic growth and targeted acquisitions, and continue building a stronger, more customer-focused company. Before moving on, I want to acknowledge the high level of engagement and commitment demonstrated by our teams across the company.

Successfully closing a major divestiture, managing the transition, returning capital to shareholders, and advancing operational improvements while continuing to serve customers at a high level requires focus, coordination, and discipline. This performance reflects the strength of our leadership team and the collaboration and accountability embedded across TriMas Corporation. Turning now to our first quarter results on Slide 4, the quarter generally reflects the expected performance across the organization and meaningful year-over-year improvement in both growth and profitability. As a reminder, the results of operations for TriMas Aerospace, which were previously reported within the Aerospace segment, along with one-time transaction-related costs, have been classified as discontinued operations for all periods presented.

For the quarter, net sales increased more than 10% year over year to $168 million. Growth was driven primarily by 7.3% organic gains, complemented by a 4% currency tailwind, and partially offset by a modest impact from the aero engine divestiture. Importantly, results reflect steady demand across many of our end markets, with Q1 net sales growth exceeding our expected range. From a profitability standpoint, we delivered solid margin expansion. Operating profit increased, with margins improving by 120 basis points year over year, and exceeding our original Q1 assumptions. This outperformance reflects operating leverage on higher volumes, combined with the early benefits of our cost streamlining initiatives, most notably meaningful reductions in corporate cash costs.

Income and earnings per share increased meaningfully year over year. Income from continuing operations increased 51% to $9 million compared to $5.9 million in the prior-year period. Adjusted earnings per share rose 60% to $0.24 compared to $0.15 in the prior year. This improvement was supported by stronger operating performance, approximately $0.04 of interest income from invested proceeds, and disciplined cost management. These benefits more than offset higher interest expense and a higher effective tax rate year over year. Overall, we are encouraged by how the year has begun. With a stronger balance sheet and a more focused portfolio, and continued progress across our operations, we believe TriMas Corporation is well positioned to accelerate performance in 2026 and beyond.

The momentum we are seeing reinforces our confidence as we move through the remainder of the year and continue advancing our strategic priorities following the aerospace divestiture. And with that, I will now turn the call over to Paul to walk through the financial results in more detail. Paul?

Paul Swart: Thank you, Thomas, and good morning, everyone. Let me start by walking through our current balance sheet and capitalization on Slide 5. We successfully closed the aerospace divestiture in March, receiving approximately $1.4 billion of gross cash proceeds, meaningfully transforming our balance sheet and providing financial flexibility. We have redeployed over $150 million of the proceeds to fund share buybacks executed between November 2025 and the end of Q1 and expect to fund the estimated $200 million in income taxes owed related to the transaction gain beginning in the second quarter. We ended the first quarter with a net cash position of $913 million.

The majority of our cash balance is invested in interest-bearing accounts, currently earning about 3.5%, a solid income source as we take a disciplined and deliberate approach to further capital redeployment. This income stream began to benefit our results in late March, and Thomas will discuss the expected earnings benefit of that interest income as part of the outlook discussion. From a debt perspective, our $400 million of 4.25% senior notes due in 2029 continue to provide stable, low-cost financing. First quarter free cash flow was a use of $16 million, which is not unusual given the seasonal dynamics of our business as we build toward higher sales volumes in the second and third quarters.

We expect improved free cash flow generation as we move throughout the year. In summary, we have significant capacity to execute our priorities and will continue to deploy capital responsibly on a measured basis to create long-term value. Turning now to business performance, let us move to Slide 6 and review the Packaging segment. First quarter net sales increased 9.1% year over year to $139.2 million, with the growth split between organic improvement and the impact of favorable foreign currency translation. Demand was solid across much of the portfolio, led by strength in applications for the beauty and personal care and life sciences end markets, partially offset by some softness in industrial closure applications.

In particular, life sciences sales benefited from nearly $5 million of tooling revenue that was not inherent in our Q1 forecast. Operating profit was $17.7 million, largely in line with the prior period. From a margin perspective, first quarter margins improved sequentially versus 2025, as expected, driven by higher sales volumes and the early benefits of our operational improvement and cost-out actions. On a year-over-year basis, margins were lower, reflecting a less favorable product sales mix, particularly as a result of the higher tooling sales, which moderated the impact of the higher volumes and cost actions during the quarter.

Turning to our forward outlook, we continue to expect full-year 2026 sales growth of 3% to 6%, with full-year operating margins expanding into the 14% to 15% range. We anticipate sequential margin expansion as we move through second quarter and then third quarter 2026, driven by cost streamlining initiatives, operational and commercial excellence programs, benefits from prior acquisition integration, and footprint optimization. Finally, as Thomas noted, we are operating in a dynamic external environment. We are actively monitoring global conditions and working proactively with our customers, suppliers, and operating teams to mitigate potential impacts from geopolitical developments. Turning to Slide 7, I will review our Specialty Products segment. Performance in the first quarter reflected continued recovery and strengthening fundamentals.

Net sales increased 17% to $29.1 million compared to $24.9 million a year ago. Year-over-year sales growth of 24% at Norris Cylinder more than offset the $1.4 million reduction in sales associated with the 2025 divestiture. This performance was supported by stronger intake, market share gains, and improving demand trends. Operating profit improved from $0.1 million in 2025 to $2.9 million, with operating profit margin increasing to 9.8%, expanding by 940 basis points year over year, driven by higher sales volumes at Norris Cylinder and improved fixed cost absorption. Looking ahead, we continue to expect full-year 2026 sales growth of 3% to 6% for Specialty Products, with operating profit margins in a range of 8% to 10%.

The ongoing recovery at Norris Cylinder is supported by stronger intake, benefits from the Made in the USA designation, and the impact of our prior cost restructuring actions, all of which are contributing to improved operating performance and margin expansion. In sum, Norris Cylinder delivered a strong start to the year, demonstrating its earnings potential and contributing positively to the company's improving financial profile. Overall, we are pleased with our start to the year. It is worth noting that Q1 was the lowest sales quarter in 2025 for both Packaging and Specialty Products segments, and the expectation has been and remains that the year-over-year growth rates will moderate as we move through 2026 to within the full-year sales growth guidance.

And with that, I will now turn the call back to Thomas to provide details on our outlook and our future. Thomas?

Thomas Snyder: Great. Thanks, Paul. I would like to spend a few minutes discussing what lies ahead for TriMas Corporation. Starting with our 2026 outlook on Slide 8, first, we are reaffirming the full-year 2026 sales and margin outlook that we previously provided on February 26. For the year, we continue to expect top-line growth of 3% to 6% based on a 2025 revenue base of $645.7 million. We also continue to anticipate more than 300 basis points of operating profit margin improvement relative to the 5.3% margin we delivered in 2025.

This represents a meaningful step change in performance driven by improved operating results across both segments and the impact of the cost reduction initiatives we have underway, which we expect to build progressively through the year. In addition, we are providing full-year 2026 adjusted diluted earnings per share guidance in the range of $1.50 to $1.70, representing a 191% increase at the midpoint compared to $0.55 in 2025. This reflects a significant year-over-year increase in earnings power driven by improved operating performance, the impact of our cost reduction actions, and interest income from the investment of divestiture proceeds.

This outlook assumes approximately $9 million of interest income for the remaining quarters and no significant changes in interest rates or redeployment of cash proceeds for the balance of the year. Key assumptions underlying this guidance also include interest expense of $20 million to $22 million, a reduction in corporate cash expense of approximately $10 million year over year as cost-out initiatives take hold, and an effective tax rate in the range of 27% to 29%.

We also expect improvement in sales, earnings, and adjusted earnings per share in each quarter of 2026 compared to the prior year, as well as sequential increases in earnings in Q2 and then Q3 2026, reflecting continued operational momentum and the progressive realization of cost-out and efficiency benefits. Now turning to Slide 9, which outlines the levers we see for long-term value creation. The story here is fairly straightforward. We have a clear strategy and a defined playbook, and we are executing against it. On the operational side, we are embedding Lean Six Sigma disciplines across our manufacturing footprint, standardizing systems and processes, and continuing to optimize our manufacturing network.

More than $10 million of savings expected in 2026, reaching more than $15 million annually, are not aspirational targets—these actions have already been taken and are progressing as planned. Innovation is another critical pillar for our long-term growth strategy. We are accelerating customer-driven product development, expanding our portfolio of sustainable product solutions, and strengthening our engineering capabilities to move faster and more effectively. Our focus is on driving growth in higher-value, higher-margin applications, particularly within life sciences and select areas of our packaging business, where we have strong customer relationships and differentiated capabilities. From a capital allocation perspective, TriMas Corporation is in a position of strength.

Following the aerospace divestiture, we ended the quarter with more than $900 million of net cash, providing substantial flexibility to invest in organic growth and pursue targeted, high-quality acquisitions. We have repurchased approximately 4.5 million shares since the aerospace sale announcement, reflecting our balanced approach to capital deployment. Enhancing and elevating our product offerings remains central to our strategy as we look ahead. Packaging and life sciences represent high-quality platforms with attractive growth profiles and strong differentiation, positioning us to drive higher-value growth and enhanced margins over time. We will continue to actively manage and refine the portfolio to advance performance, elevate our strategic profile, and create sustained long-term value.

In summary, we delivered a strong start for the year with more than 10% sales growth, 60% adjusted earnings per share growth, and 120 basis point operating margin expansion, while advancing multiple levers that support sustained momentum. With a stronger operating foundation and meaningful capital to deploy, we believe TriMas Corporation is well positioned to accelerate performance in 2026 and beyond, deepen customer partnerships, and invest in the opportunities that create the greatest long-term value. Thank you. And with that, I will turn the call back to you, Sherry.

Sherry Lauderback: Thanks, Thomas. At this point, we would like to open the call to questions from our analysts. Thank you. We will now be conducting a question-and-answer session. A confirmation tone will indicate that your line is in the question queue. You may press star 2 if you would like to remove your question from the queue. For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star keys. One moment, please, while we poll for questions. Our first question comes from Hamed Khorsand with BWS Financial. Please proceed with your question.

Operator: Hamed, it looks like we lost you. If you could join back the queue, that would be great. We will move over to Katie Fleischer with KeyBanc Capital Markets. Please proceed with your question.

Katie Fleischer: Hey. Good morning, everyone. Can you talk about some price/cost expectations within Packaging and remind us what the typical lag versus commodity prices is before it flows through to the P&L?

Thomas Snyder: Yes, sure. It is typical in this industry—there is usually a bit of a lag on the resin cost pass-through. Our team has been all over this. We have, obviously, a majority of our business under contract with language that recovers our costs. We do a variety of different term timing periods to recover that. But the way that we have looked at this, we do not anticipate a lot of impact. There could be some headwind in the quarter with some delay—let us say, moving from Q2 to Q3—but overall, not all that significant. And from a full-year perspective, I feel pretty good about the price-over-cost recovery.

I do not know, Paul, if you have anything to add to that.

Paul Swart: Yes, Katie, I would say the more prevalent contract term is quarterly, as opposed to monthly or other escalators. So while we are not providing specific quarterly guidance, I do think that there is the potential—because of some of the things that started to happen in March—that we may not get full recovery on some of it until the third quarter or later in the year. So we are kind of planning internally—we talked about margin accretion from first quarter to second quarter, and then from second quarter to third quarter. Part of that is premised on our cost-out actions, where we are going to get more savings in second quarter and then third quarter compared to first.

Part of that is also the thinking at the moment relative to recovery timing of commodity costs. It is likely that we may be a little bit short here as we move into second quarter and then begin to overcome that in third quarter.

Katie Fleischer: Got it. Okay. That is helpful. And then, turning to Packaging margins, how should we think about the cadence of improvement within that segment through the year, just given the cost savings from the facility consolidation, but then layered in with some of those mix impacts that we saw this quarter?

Paul Swart: I would say it is very consistent with what my prior comments were. I think we expected Q1 to be the lowest from a margin perspective, and we expect margins to increase sequentially as we move through the year. Obviously, there is a little bit of uncertainty in terms of the sales volumes—sometimes Q2 is the highest sales quarter, sometimes Q3 is—but I would expect that the actions we are taking are sufficient such that you are going to see escalation as you move through the next two quarters. Then Q4 naturally falls back a little bit, but we would be in line with our full-year guidance.

Katie Fleischer: And then just to squeeze one more in here on the mix impacts. I think I heard you say that was from tooling revenue within life sciences. Can you give a little more detail on that, and if we should see that in coming quarters?

Paul Swart: Sure. We had a tooling sale for a program that we are working on where we are going to ultimately put product into production later in the year or early next year, but we created and sold the tooling at a very low margin to the ultimate customer. That really did not provide a lot at the bottom line and was not inherent in what our Q1 guidance was—it was expected a little bit later in the year. So that pressured our margins in Q1 just because of that significant one-time sale.

There is not another significant tooling sale that we currently have forecasted that is inherent in our guidance, so we do not expect that margin pressure to occur for the remainder of the year. Obviously, we will update you if something changes, but that is where we stand right now.

Thomas Snyder: Yes, it is actually a good thing. I always look at these things as a leading indicator of significant improvements in sales down the road, so more to come on that as the clock moves forward.

Sherry Lauderback: We have reached the end of our question-and-answer session. I would now like to turn the floor back over to management for closing comments. Once again, thank you for joining us today and for your continued interest in TriMas Corporation. We appreciate your ongoing support, and we look forward to updating you on our progress next quarter.

Thomas Snyder: Thank you.

Operator: This concludes today's teleconference. You may disconnect your lines at this time. Thank you for your participation.

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. Parts of this article were created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.